University of Mississippi4h
Study Explores Compound's Potential to Enhance THC for Pain Treatment
When THC attaches to the receptor, the effect is like an off switch to a light bulb, effectively turning "off" the pain. But ...
Oncology Nurse Advisor9h
Journavx, a Nonopioid Oral Pain Medication, Gets FDA Approval
The Food and Drug Administration (FDA) has approved Journavx™ (suzetrigine) for the treatment of moderate to severe acute pain in adults.
The Scientist1d
“Man on Fire” Syndrome, Ion Channels, and the Quest for Safer Pain Treatments
In 2004, a research group at Peking University First Hospital discovered a mutation in the gene coding for a sodium-channel ...
A first in 25 years: FDA approves new type of painkiller
The drug offers a non-addictive alternative to opioids, marking 'an important public health milestone in acute pain ...
BioWorld5d
Vertex wins FDA nod for Journavx, new mechanism for acute pain
An effort two decades in the making, Vertex Pharmaceuticals Inc.’s suzetrigine gained U.S. FDA approval as the first drug targeting the NaV1.8 pain signal. Branded Journavx, the oral small molecule is ...
FDA approves first non-opioid pain medicine in more than 20 years
The Food and Drug Administration announced the approval of a new non-opioid pain medication this week, marking the first time ...
FDA approves new pain medication as an alternative to opioids: What to know about Journavx
The FDA on Thursday approved a new class of pain medication that provides an alternative to opioids. It will be sold under ...
Stars and Stripes6d
FDA approves painkiller designed to eliminate the risk of addiction associated with opioids
WASHINGTON — Federal officials on Thursday approved a new type of pain pill designed to eliminate the risks of addiction and ...